Location History:
- Scotland, GB (2007)
- Newhouse, GB (2010)
Company Filing History:
Years Active: 2007-2010
Title: Phillip Martin Cowley: Innovator in Pharmaceutical Chemistry
Introduction
Phillip Martin Cowley is a notable inventor based in Newhouse, GB. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds aimed at treating various medical conditions. With a total of 2 patents to his name, Cowley's work is recognized for its potential therapeutic applications.
Latest Patents
Cowley's latest patents include innovative compounds that have promising uses in medicine. The first patent focuses on 1-benzylindole-2-carboxamide derivatives. This invention relates to these derivatives of formula I, or a pharmaceutically acceptable salt or solvate thereof. The invention also encompasses pharmaceutical compositions comprising these derivatives and their application in therapy, particularly for treating obesity or nicotine dependence. The second patent involves 1-[(indol-3-yl)carbonyl]piperazine derivatives. This invention pertains to these derivatives according to the general formula I or a pharmaceutically acceptable salt thereof. It also includes pharmaceutical compositions comprising these derivatives and their use in treating various types of pain, including peri-operative pain, chronic pain, neuropathic pain, cancer pain, and pain associated with multiple sclerosis.
Career Highlights
Cowley is currently associated with N.V. Organon, where he continues to advance his research and development efforts. His work has contributed to the understanding and treatment of complex medical conditions, showcasing his commitment to improving patient outcomes through innovative solutions.
Collaborations
Cowley has collaborated with notable colleagues such as Wilson Caulfield and Jason Tierney. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Phillip Martin Cowley is a distinguished inventor whose work in pharmaceutical chemistry has led to significant advancements in therapeutic applications. His innovative patents reflect his dedication to addressing critical health issues through scientific research and collaboration.